Roche’s CT-388 Delivers 22.5% Placebo-Adjusted Wei...
Category : Clinical Trial Update 28 January 2026Roche reported positive topline results from CT388-103, a Phase II study of CT-388, its investigatio...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bausch Health’s Phase 3 RED-C Program for Rifaximi...
Category : Clinical Trial Update 28 January 2026Bausch Health Companies Inc. announced topline results from its global phase 3 RED-C clinical progra...
NuLiv Science Preclinical Study Shows AstraGin® Su...
Category : Product Related Updates 28 January 2026NuLiv Science has released results from a new preclinical study evaluating AstraGin®, its patent...
European Commission Approves Ionis and Otsuka’s Da...
Category : Approval/Launch 27 January 2026Ionis Pharmaceuticals and Otsuka Pharmaceutical have received European Commission approval for Dawnz...
Novo Medi Sciences Launches Nexipox Plus, India-Sp...
Category : Approval/Launch 27 January 2026Novo Medi Sciences Pvt. Ltd. has launched Nexipox Plus, a next-generation varicella (chickenpox) vac...
Latest Newsletter Post
-
NuLiv Science Preclinical Study Sho..
28 January 2026
-
Bausch Health’s Phase 3 RED-C Progr..
28 January 2026
-
Roche’s CT-388 Delivers 22.5% Place..
28 January 2026
-
Sanofi’s Amlitelimab Delivers Posit..
27 January 2026
-
Novo Medi Sciences Launches Nexipox..
27 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com